SYNDAX PHARMACEUTICALS INC filings

All
Holdings
Significant ownership
Insider transactions
Annual reports
Quarterly reports
Events
Shareholder votes
SEC filings by SYNDAX PHARMACEUTICALS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G/A2020-02-14Access Industries Holdings LLCSyndax Pharmaceuticals Inc3,028,7429.9%EDGAR
SC 13G/A2020-02-13683 Capital Management, LLCSyndax Pharmaceuticals Inc1,153,3734.2%EDGAR
SC 13G/A2020-02-12ADAGE CAPITAL PARTNERS GP, L.L.C.Syndax Pharmaceuticals Inc1,250,0004.6%EDGAR
SC 13G/A2020-02-06BlackRock Inc.Syndax Pharmaceuticals Inc1,714,4816.3%EDGAR
SC 13G/A2020-01-28WELLINGTON MANAGEMENT GROUP LLPSyndax Pharmaceuticals Inc3,043,69011.2%EDGAR
SC 13G2019-10-09Access Industries Holdings LLCSyndax Pharmaceuticals Inc1,657,9486.1%EDGAR
SC 13G2019-04-08ADAGE CAPITAL PARTNERS GP, L.L.C.Syndax Pharmaceuticals Inc1,550,0005.7%EDGAR
SC 13G/A2019-02-14BIOTECHNOLOGY VALUE FUND L PSyndax Pharmaceuticals Inc1,396,1485.5%EDGAR
SC 13G/A2019-02-14683 Capital Management, LLCSyndax Pharmaceuticals Inc1,342,8395.4%EDGAR
SC 13G/A2019-02-12WELLINGTON MANAGEMENT GROUP LLPSyndax Pharmaceuticals Inc3,241,78213.0%EDGAR
SC 13G/A2019-02-12MPM BioVentures IV QP LPSyndax Pharmaceuticals Inc1,806,7597.3%EDGAR
SC 13G2019-02-08BlackRock Inc.Syndax Pharmaceuticals Inc1,574,9316.3%EDGAR
SC 13G2018-11-29683 Capital Management, LLCSyndax Pharmaceuticals Inc1,245,0005.0%EDGAR
SC 13G/A2018-02-14BIOTECHNOLOGY VALUE FUND L PSyndax Pharmaceuticals Inc1,603,4166.6%EDGAR
SC 13G/A2018-02-08WELLINGTON MANAGEMENT GROUP LLPSyndax Pharmaceuticals Inc3,414,59014.0%EDGAR
SC 13G/A2018-02-02MPM BioVentures IV QP LPSyndax Pharmaceuticals Inc1,806,7597.4%EDGAR
SC 13G/A2017-12-11FMR LLCSyndax Pharmaceuticals Inc727,3443.0%EDGAR
SC 13G/A2017-12-07BlackRock Inc.Syndax Pharmaceuticals Inc915,9013.8%EDGAR
SC 13G/A2017-11-17BIOTECHNOLOGY VALUE FUND L PSyndax Pharmaceuticals Inc1,255,4525.1%EDGAR
SC 13G2017-11-14BIOTECHNOLOGY VALUE FUND L PSyndax Pharmaceuticals Inc947,3503.9%EDGAR
External links